Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of KVK-TECH, INC..

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
KVK-TECH, INC.
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
KVK-TECH, Inc. 110 Terry Drive, Suite 200 Newtown, PA 18940 United States of America
Telephone
Telephone
 (215)-579-1842
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

SJP-002C (ketotifen) world most potent, orally available anti-inflammatory a person could obtain for a mild to moderate coronavirus infection, Sen-Jam's investigational therapeutic for treatment of COVID-19, SJP-002C is now actively enrolling patients for their clinical trial.


Lead Product(s): Ketotifen Fumarate,Indomethacin

Therapeutic Area: Infections and Infectious Diseases Product Name: SJP-002C

Highest Development Status: Phase IIProduct Type: Small molecule

Recipient: Sen-Jam Pharmaceutical

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 06, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

KVK will have exclusive manufacturing and supply rights for the product SJP-002C (Ketotifen) in the US. Sen-Jam will utilize the finished formulation and CMC report to enter licensing deals with contracting manufacturing companies (CMOs) globally.


Lead Product(s): Ketotifen Fumarate,Indomethacin

Therapeutic Area: Infections and Infectious Diseases Product Name: SJP-002C

Highest Development Status: Phase IIProduct Type: Small molecule

Recipient: Sen-Jam Pharmaceutical

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration May 05, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Sen-Jam Pharmaceutical has entered a development, manufacturing, distribution, and license agreement with KVK-Tech. This is a monumental milestone for the company and great news for their promising oral COVID-19 treatment, SJP-002C.


Lead Product(s): Ketotifen Fumarate,Indomethacin

Therapeutic Area: Infections and Infectious Diseases Product Name: SJP-002C

Highest Development Status: Phase IIIProduct Type: Small molecule

Recipient: Sen-Jam Pharmaceutical

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership March 22, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY